CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

151 hedge funds and large institutions have $1.02B invested in Cymabay Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 32 closing their positions.

Holders
151
Holders Change
+12
Holders Change %
+8.63%
% of All Funds
2.38%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.14%
New
45
Increased
42
Reduced
39
Closed
32
Calls
$3.85M
Puts
$225K
Net Calls
+$3.62M
Net Calls Change
+$531K

Top Buyers

1
BlackRock
1
BlackRock
New York
$82.2M
2
CAM
2
Cormorant Asset Management
Massachusetts
$41.6M
3
NHAS
3
Novo Holdings A/S
Denmark
$21.9M
4
State Street
4
State Street
Massachusetts
$25.3M
5
Jennison Associates
5
Jennison Associates
New York
$18.3M

Top Sellers

1
TCM
1
TCG Crossover Management
California
$0
2
LCM
2
Laurion Capital Management
New York
$2.35M
3
Millennium Management
3
Millennium Management
New York
$15.8M
4
NCM
4
Nantahala Capital Management
Connecticut
$6.06M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
26
Two Sigma Investments
New York
$9.59M -$5.95M -543,652 -38%
Deutsche Bank
27
Deutsche Bank
Germany
$9.04M +$4.72M +430,868 +109%
Morgan Stanley
28
Morgan Stanley
New York
$9.02M -$1.85M -168,682 -17%
Marshall Wace
29
Marshall Wace
United Kingdom
$8.56M +$5.9M +538,554 +221%
NIP
30
Nicholas Investment Partners
California
$7.63M +$7.63M +696,947 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$7.58M +$1.57M +143,357 +26%
ACM
32
Altium Capital Management
New York
$7.32M +$533K +48,702 +8%
Goldman Sachs
33
Goldman Sachs
New York
$6.28M -$2.19M -200,201 -26%
OM
34
Opaleye Management
Massachusetts
$6.21M +$6.21M +566,700 New
NCM
35
Nantahala Capital Management
Connecticut
$6.06M -$13.5M -1,236,796 -69%
VVM
36
Versant Venture Management
California
$5.95M – – –
Citadel Advisors
37
Citadel Advisors
Florida
$4.92M +$1.35M +123,576 +38%
ACP
38
Acuta Capital Partners
California
$4.71M -$4.91M -448,500 -51%
JPMorgan Chase & Co
39
JPMorgan Chase & Co
New York
$4.64M -$1.3M -118,946 -22%
Voloridge Investment Management
40
Voloridge Investment Management
Florida
$4.19M -$2.86M -261,340 -41%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$4.13M +$3.7M +337,506 +844%
SCM
42
Soleus Capital Management
Connecticut
$4.08M +$4.08M +373,000 New
EI
43
EAM Investors
California
$4.08M +$614K +56,030 +18%
HS
44
HighVista Strategies
Massachusetts
$3.71M -$97.9K -8,944 -3%
Nuveen Asset Management
45
Nuveen Asset Management
Illinois
$3.27M +$3.27M +298,875 New
WP
46
Woodline Partners
California
$3.13M – – –
Renaissance Technologies
47
Renaissance Technologies
New York
$2.96M -$2.32M -211,480 -44%
Charles Schwab
48
Charles Schwab
California
$2.9M +$2.48M +226,254 +588%
Prudential Financial
49
Prudential Financial
New Jersey
$2.64M +$2.64M +241,110 New
Walleye Capital
50
Walleye Capital
New York
$2.57M +$2.57M +234,643 New
1
2
3 4 5